Isaac Ro is a Partner at Catalio Capital Management, LP, serving on multiple boards. He previously held CFO roles at Sema4 and Thrive Earlier Detection, and led equity research at Goldman Sachs.

What Isaac can write

Writes checks ofNot reported
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Email the firm[email protected]The firm's own inbox for founders.

Career

  1. Leerink Partners · same role
  2. Goldman Sachs · led U.S. Medical Technology and Life Science Tools equity research teams
    2010-2019
  3. Thrive Earlier Detection · Chief Financial Officer
  4. Sema4 · Chief Financial Officer
  5. Catalio Capital Management, LP · Partner
    Now
  6. Leerink Partners
  7. Goldman Sachs
    2010-2019
  8. Haystack Oncology · Executive Chairman

Investments named in public bios

Pink Dx.PrognomiQVisby MedicalHaystack OncologyGeneDx

Focus

medical technologylife science toolshealthcare

Education

Middlebury College

Also at Catalio Capital Management

Partners like Isaac

At firms with a similar stage, sector and check size.

Alert me when Catalio Capital Management is active

One email when Isaac's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Isaac Ro?

Isaac Ro is a Partner at Catalio Capital Management, LP, serving on multiple boards. He previously held CFO roles at Sema4 and Thrive Earlier Detection, and led equity research at Goldman Sachs.

How much does Isaac Ro invest?

Catalio Capital Management has not reported a check size. It invests at pre-seed, seed, series a, series b.

How do I pitch Isaac Ro?

Email [email protected], the firm's inbox for founders, and name Isaac in the subject. A warm intro from a founder Catalio Capital Management backed works better.

What did Isaac Ro do before Catalio Capital Management?

same role at Leerink Partners; led U.S. Medical Technology and Life Science Tools equity research teams at Goldman Sachs; Chief Financial Officer at Thrive Earlier Detection; Chief Financial Officer at Sema4; Leerink Partners; Goldman Sachs; Executive Chairman at Haystack Oncology.

Last updated 2026-10-15. Is this you? Ask for a correction.